Published
talked to the client's endocrinologist. he stated that there is no risk in rotating sites with DDAVP given sc. i also learned that when giving insulin, the benefits of rotating sites and reducing skin irritation/ lipohypertrophy outweighs the negative of a slightly variable insulin level :) so good to know!
BeatsPerMinute, BSN, RN
398 Posts
I know that when giving insulin or teaching diabetic clients about insulin injections, that it is important to rotate injection sites within the same anatomical area (rotate sites to reduce skin irritation, remain in the same region - abd, arm, leg - because absorption rates differ and changing regions can cause variability in insulin levels). Is this also true for clients with diabetes insipidus who receive DDAVP? I can't find anything about it.